Join the club for FREE to access the whole archive and other member benefits.

Matthias Breugelmans

Life science entrepreneur and CEO of Elastrin Therapeutics

Matthias Breugelmans is a life science entrepreneur and CEO of Elastrin Therapeutics. He has a master’s degree in Pharmaceutical Sciences and a PhD in Medicinal Chemistry. He worked in the pharmaceutical industry at Grünenthal in the Drug Safety department and later as OE / Business Transformation Consultant and Performance and Improvement Lead.

Visit website: https://silversky-lifesciences.com/matthias-breugelmans#:~:text=Dr.%20Matthias%20Breugelmans%20Dr.%20Matthias%20Breugelmans%20has%20a,Business%20Transformation%20Consultant%20and%20Performance%20and%20Improvement%20Lead.

matthiasbreugelmans

See also

Elastrin Therapeutics

South Carolina-based biotech developing novel therapies

Details last updated 06-Mar-2021

Matthias Breugelmans News

Reason reports back from October's Rejuvenation Startup Summit

Reason reports back from October's Rejuvenation Startup Summit

Fight Aging! - 19-Oct-2022

Some really exciting developments with quite a few in clinical trials

Elastrin's novel therapies to reverse age-related vascular damage

Elastrin's novel therapies to reverse age-related vascular damage

Longevity Technology - 04-Mar-2021

Advancing technologies for tissue and organ rejuvenation with seed funding from Kizoo

Matthias Breugelmans is also referenced in the following:

Longevity Summit Dublin 2023

17-Aug-2023 to 20-Aug-2023
Club discount available - click here

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

DoNotAge supplements affiliate link